Press release
Asthma Treatment Market Outlook: USD 26.10 billion by 2030 with Impressive 4.6% CAGR
Asthma Treatment Market
๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐ซ๐๐ฌ๐ฌ๐๐ฌ:
โข The global asthma treatment market was valued at USD 17.85 billion in 2021 and is expected to grow to USD 26.10 billion by 2030.
โข The market is anticipated to exhibit a CAGR of 4.6% during the forecast period.
โข The market is mainly segmented on the basis of drug class, device type, route of administration, and region.
โข North America accounted for the largest market share.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/global-asthma-treatment-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Prohibition and prolonged regulation are critical to halting asthma censure prior to their commencement. Treatment normally includes assimilating to identify the triggers, captivating measures to circumvent triggers, and tracing the inhaling to ascertain the medications are sustaining indications under regulation. In case of an asthma break, one may require an assuaged inhaler. The appropriate medications rely on a number of factors such as age, indications, asthma triggers, and what works best to sustain asthma under regulation. Deterrent prolonged regulatory medicines lessen the swelling in the airways that causes indications. The comfort inhalers swiftly unfurl swollen airways that restrict breathing.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐จ๐ง ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐ณ๐๐ญ๐ข๐จ๐ง
The firms broadly hold the biggest market share and dominate industry trends. Key companies in the asthma treatment market are mentioned below:
โข Abbott
โข Amgen
โข AstraZeneca plc.
โข Biogen
โข Boehringer Ingelheim International GmbH
โข F. Hoffmann-La Roche Ltd
โข GlaxoSmithKline plc.
โข Merck & Co. Inc.
โข Mylan N.V.
โข Novartis AG
โข Roche AG
โข Sanofi
โข Sunovion Pharmaceuticals
โข Teva Pharmaceutical Industries
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/global-asthma-treatment-market/inquire-before-buying
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ
Some market elements, such as concentration on proliferating consciousness about asthma treatment options, for instance, crushed meter portion inhalers and dry powder inhalers, are authorizing the market. Growing acquisition rates because of the elevated effectiveness of protracted muscarinic adversary inhaled corticosteroid, long-acting beta2 agonist-inhaled corticosteroid, and alternate merger symptoms and delayed managerial approvals have constrained the acceptance of blend cure in the asthma treatment market growth.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Russia, Spain)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Asthma Treatment, Drug Class Outlook (Revenue - USD Billion, 2018 - 2030)
โข Anti-inflammatory
โข Bronchodilators
โข Combination Therapy
โข Others
Asthma Treatment, Device Type Outlook (Revenue - USD Billion, 2018 - 2030)
โข Dry Powder Inhalers
โข Metered Dose Inhalers
โข Soft Mist Inhalers
โข Nebulizers
โข Others
Asthma Treatment, Route of Application Outlook (Revenue - USD Billion, 2018 - 2030)
โข Oral
โข Inhaled
โข Intravenous
โข Subcutaneous
โข Others
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐:
https://www.polarismarketresearch.com/industry-analysis/global-asthma-treatment-market
๐๐ฌ๐ญ๐ก๐ฆ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข North America market is expected to register one of the highest cases of asthma cure due to the increasing number of cases yearly.
โข The intravenous segment is expected to register the fastest growth during the forecast period. FDA has approved Tezspire, which would act as an add-on cure for severe cases that regular medications can't control. Tezspire is extraordinary because it isn't restricted to a particular kind of extreme breathing problems. It focuses on a type of particle engaged with aviation route irritation. FDA approves the drug after its two successful trials.
โข In July 2020, AstraZeneca's outcomes from the positive Phase III ETHOS preliminary were distributed in the New England Journal of Medicine. The review showed that the triple-mix treatment PT010 (budesonide/glycopyrronium/formoterol fumarate) reduced the rate of moderate or extreme intensifications compared with two double blend treatments in patients with moderate to severe COPD.
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
U.S. Induced Pluripotent Stem Cell (iPSC) Market: https://www.polarismarketresearch.com/industry-analysis/us-induced-pluripotent-stem-cell-ipsc-market
Europe Induced Pluripotent Stem Cell (iPSC) Market: https://www.polarismarketresearch.com/industry-analysis/europe-induced-pluripotent-stem-cell-ipsc-market
Cancer Cachexia Market: https://www.polarismarketresearch.com/industry-analysis/cancer-cachexia-market
Oligonucleotide Synthesis Market: https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma Treatment Market Outlook: USD 26.10 billion by 2030 with Impressive 4.6% CAGR here
News-ID: 3670326 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Treatment
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea โฆ
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 toโฆ
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,โฆ
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, โฆ
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,โฆ
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti โฆ
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in anyโฆ
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr โฆ
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose ofโฆ
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M โฆ
Transparency Market Research (TMR) has published a new report titled โAddiction Treatment Market โ Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017โ2025โ. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smokingโฆ
